Cancer-associated fibroblasts in hepatocellular carcinoma: origins, heterogeneity, and therapeutic implications
Hepatocellular carcinoma (HCC) is a globally prevalent malignancy. This disease often progresses rapidly, resulting in many patients being diagnosed at a late stage, making early detection and intervention a major clinical challenge. Postoperative recurrence and metastasis rates remain significantly...
Saved in:
| Main Authors: | Xin Shi, Weixiong Zhu, Jianpeng Zhang, Chuanlei Fan, Jing Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1620075/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development
by: Guoming Chen, et al.
Published: (2025-07-01) -
Fibroblast activation protein and the tumour microenvironment: challenges and therapeutic opportunities
by: Hsing Hwa Lee, et al.
Published: (2025-07-01) -
Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities
by: Man Wang, et al.
Published: (2025-06-01) -
Cancer-associated fibroblast-mediated immune evasion: molecular mechanisms of stromal-immune crosstalk in the tumor microenvironment
by: Junling Luo, et al.
Published: (2025-08-01) -
Cancer-associated fibroblasts: multidimensional players in liver cancer
by: Yanyun Pan, et al.
Published: (2025-04-01)